Rasayani Biologics

Rasayani Biologics is a clinical-stage research and development company that bridges the gap between Ayurvedic principles and modern pharmacology. Utilizing a patented green nanotechnology platform, the company specializes in synthesizing nanoparticles of noble metals and base elements to create novel, orally administrable therapeutics. Its pipeline includes NTPX-07 (Bioplatin), an oral nano-platinum compound for solid tumors; NTAX-44, an oral arsenic trioxide formulation targeting glioblastoma and other malignancies; and NTGX-10 (Timirex-R), an oral gold compound for diabetic retinopathy. Rasayani Biologics employs a 'bedside-to-bench' reverse pharmacology approach to accelerate drug development and reduce clinical failure rates.